The Role of Chromosome Deletions in Human Cancers

被引:9
|
作者
Chen, Mei [1 ,2 ,3 ]
Yang, Yi [1 ,2 ,3 ]
Liu, Yu [1 ,2 ,3 ]
Chen, Chong [1 ,2 ,3 ]
机构
[1] Sichuan Univ, Dept Hematol, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, Ctr Canc, West China Hosp, Chengdu, Sichuan, Peoples R China
[3] Natl Collaborat Innovat Ctr, Chengdu, Sichuan, Peoples R China
来源
CHROMOSOME TRANSLOCATION | 2018年 / 1044卷
关键词
Chromosome deletion; Human cancer; Knudson's two-hit hypothesis; Haploinsufficient tumor suppressor; Genome editing; TUMOR-SUPPRESSOR GENE; COMPARATIVE GENOMIC HYBRIDIZATION; ACUTE LYMPHOBLASTIC-LEUKEMIA; PLURIPOTENT STEM-CELLS; ACUTE MYELOID-LEUKEMIA; ABL TYROSINE KINASE; MYELODYSPLASTIC SYNDROMES; CLINICAL ASSOCIATIONS; TP53; MUTATIONS; HETEROZYGOSITY;
D O I
10.1007/978-981-13-0593-1_9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Chromosome deletions are a hallmark of human cancers. These chromosome abnormalities have been observed for over than a century and frequently associated with poor prognosis. However, their functions and potential underlying mechanisms remain elusive until recently. Recent technique breakthroughs, including cancer genomics, high throughput library screening and genome editing, opened a new era in the mechanistic studying of chromosome deletions in human cancer. In this chapter, we will focus on the latest studies on the functions of chromosome deletions in human cancers, especially hematopoietic malignancies and try to persuade the readers that these chromosome alterations could play significant roles in the genesis and drug responses of human cancers.
引用
收藏
页码:135 / 148
页数:14
相关论文
共 50 条
  • [41] PROGNOSTIC IMPLICATIONS OF CHROMOSOME 17P DELETIONS IN HUMAN MEDULLOBLASTOMAS
    BATRA, SK
    MCLENDON, RE
    KOO, JS
    CASTELINOPRABHU, S
    FUCHS, HE
    KRISCHER, JP
    FRIEDMAN, HS
    BIGNER, DD
    BIGNER, SH
    JOURNAL OF NEURO-ONCOLOGY, 1995, 24 (01) : 39 - 45
  • [42] Chromosome and gene alterations in human cancers in relation to aging
    Dutrillaux, BH
    CHROMOSOMES TODAY, VOL 13, 2000, 13 : 207 - 223
  • [43] The role of chromosome arm 3p and human papillomavirus on proliferation, differentiation, and metastasis in squamous cancers
    Mallick, Samyukta
    Taylor, Alison M.
    CANCER RESEARCH, 2023, 83 (07)
  • [44] Chromosome healing of constitutional chromosome deletions studied by microdissection
    Vermeesch, JR
    Falzetti, D
    Van Buggenhout, G
    Fryns, JP
    Marynen, P
    CYTOGENETICS AND CELL GENETICS, 1998, 81 (01): : 68 - 72
  • [45] Coincidence of synteny breakpoints with malignancy-related deletions on human chromosome 3
    Kost-Alimova, M
    Kiss, H
    Fedorova, L
    Yang, Y
    Dumanski, JP
    Klein, G
    Imreh, S
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (11) : 6622 - 6627
  • [46] Mapping of genetic deletions on the long arm of chromosome 4 in human esophageal adenocarcinomas
    Rumpel, CA
    Powell, SM
    Moskaluk, CA
    AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (05): : 1329 - 1334
  • [47] Genome and gene alterations by insertions and deletions in the evolution of human and chimpanzee chromosome 22
    Natalia Volfovsky
    Taras K Oleksyk
    Kristine C Cruz
    Ann L Truelove
    Robert M Stephens
    Michael W Smith
    BMC Genomics, 10
  • [48] Are sequence family variants useful for identifying deletions in the human Y chromosome? Reply
    Fernandes, S
    Paracchini, S
    Meyer, LH
    Floridia, G
    Tyler-Smith, C
    Vogt, PH
    AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 75 (03) : 517 - 519
  • [49] Mapping of genetic deletions on the long arm of chromosome 22 in human pancreatic adenocarcinomas
    Handel-Fernandez, ME
    Nassiri, M
    Arana, M
    Perez, MM
    Fresno, M
    Nadji, M
    Vincek, V
    ANTICANCER RESEARCH, 2000, 20 (6B) : 4451 - 4456
  • [50] Mapping of chromosome 3p deletions in human epithelial ovarian tumors
    Hafida Lounis
    Anne-Marie Mes-Masson
    France Dion
    W Edward C Bradley
    Robert J Seymour
    Diane Provencher
    Patricia N Tonin
    Oncogene, 1998, 17 : 2359 - 2365